Search results for "Atrial fibrillation"
Stronger warning for montelukast; COVID-19 actions
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2020/05/stronger-warning-for-montelukast-covid-19-actions.htm
1 May 2020
Dabigatran may interact with BP meds in patients with afib and normal kidney function
U.S. guidance currently recommends a lower dabigatran dose in those taking P-glycoprotein inhibitors only if kidney function is impaired.
https://immattersacp.org/weekly/archives/2020/04/28/4.htm
28 Apr 2020
Dual therapy for afib after PCI may reduce bleeding risk better than triple therapy
Researchers reviewed four randomized controlled trials of 7,953 patients that compared the effects of dual versus triple therapy on bleeding, mortality, and ischemic events after percutaneous coronary intervention (PCI).
https://immattersacp.org/weekly/archives/2020/03/17/4.htm
17 Mar 2020
Apixaban may be safer, more effective than rivaroxaban for afib
Patients taking rivaroxaban had higher rates of stroke or systemic embolism and gastrointestinal or brain bleeding compared to those taking apixaban, according to a retrospective cohort study.
https://immattersacp.org/weekly/archives/2020/03/10/4.htm
10 Mar 2020
Intervention targeting clinicians did not increase anticoagulation use in patients with afib
Electronic messaging and academic detailing improved clinicians' comfort with prescribing anticoagulation in certain situations, but rates of appropriate anticoagulation for atrial fibrillation did not change significantly, a trial found.
https://immattersacp.org/weekly/archives/2020/02/25/4.htm
25 Feb 2020
Wrestling with wearables that screen for afib
Experts remain uncertain how to judge wearables and smartphone apps' cost-effectiveness, data quality, and clinical implications among pre-symptomatic patients diagnosed with atrial fibrillation.
https://immattersacp.org/archives/2020/02/wrestling-with-wearables-that-screen-for-afib.htm
1 Feb 2020
New warnings for gabapentinoids; other drugs approved
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2020/02/new-warnings-for-gabapentinoids-other-drugs-approved.htm
1 Feb 2020
Alcohol abstinence may reduce secondary atrial fibrillation, randomized trial finds
An editorial noted the potential difficulty of convincing patients who drink regularly to abstain from alcohol long enough to make a difference.
https://immattersacp.org/weekly/archives/2020/01/07/2.htm
7 Jan 2020
New report proposes solutions to drug shortages
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2020/01/new-report-proposes-solutions-to-drug-shortages.htm
1 Jan 2020
Non-vitamin K oral anticoagulants appear superior to vitamin K antagonists in early-stage CKD
An accompanying editorial said that the current review supports a superior benefit profile of non-vitamin K oral anticoagulants (NOACs) in patients with atrial fibrillation and early-stage chronic kidney disease (CKD).
https://immattersacp.org/weekly/archives/2019/07/16/2.htm
16 Jul 2019